Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)

NCT02687399 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Osteoarthritis

Interventions

OTHER: placebo
BIOLOGICAL: TT-173

Sponsor

Thrombotargets Europe S.L